SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Two Teva insiders, including a senior executive (Sabag Mark, See…

TEVA PHARMACEUTICAL INDUSTRIES LTD · CLUSTER filed Nov 6, 2026 at 16:03 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Nov 6, 2026 at 16:03 ET

Two Teva insiders, including a senior executive (Sabag Mark, See Remarks), sold shares in open-market transactions totaling $2.29M in the days following the company's Q3 2026 earnings beat and raised guidance. The sales are not under 10b5-1 plans and represent 0.005% of market cap, a trivial amount relative to the $48.8B valuation.

  • Two insiders executed open-market sales (code S) totaling $2.29M, none under 10b5-1 plans
  • Sabag Mark sold 46,000 shares at $41.93 for $1.93M on 2026-11-05
  • Bergwerk Dov sold 17,505 shares at $41.72 for $730K and 8,755 shares at $41.72 for $365K on 2026-11-04
  • Sales occurred 1-2 days after Teva reported Q3 2026 non-GAAP EPS of $0.86 (beat consensus by 19.4%) and revenue of $4.395B (above $4.23B consensus)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access